Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sohier M Ahmed"'
Autor:
Sohier M Ahmed, Lobna F. ElToni, John Burthem, Safaa A. A. Khaled, El-Badry E. Abo Elnoor, Hanan M. Ahmed
Publikováno v:
Journal of Hematology
Background: In our previous work, we provided strong evidence that nucleophosmin (NPM) gene mutation has an important role in leukemogenesis of primary acute myeloid leukemia (AML). Furthermore, we speculated a new targeted therapy in patients with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b55b03a18551f2fdc9c2fc208db71d
https://doi.org/10.14740/jh390
https://doi.org/10.14740/jh390
Autor:
Lobna F. ElToni, El-Badry E. Abo Elnoor, Sohier M Ahmed, Hanan M. Ahmed, John Burthem, Safaa A. A. Khaled
Publikováno v:
Journal of Hematology
Background: Acute myeloid leukemia (AML) is a hematopoietic stem cell disorder that carries very poor prognosis. Understanding molecular basis of AML leukemogenesis could lead to the emergence of effective targeted therapies for AML. AML bearing nucl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba437ecaebb06f12f98300eef15d0123
http://europepmc.org/articles/PMC7155854
http://europepmc.org/articles/PMC7155854
Autor:
Lobna F ELTony, Hanan M. Ahmed, El Badry E Abu-ElNoor, Sohier M Ahmed, Safaa A. A. Khaled, John Burthem
Publikováno v:
The Egyptian Journal of Haematology. 40:190
Background The current approach of treating de-novo acute myeloid leukemia (AML) is still ineffective. This is in part due to the clinical and molecular diversity of the disease. Accordingly, development of new effective targeted therapies for AML is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5752a6eacb93c82491d49132c77cead
https://doi.org/10.4103/1110-1067.170220
https://doi.org/10.4103/1110-1067.170220